Oncogenic microrna-27a is a target for genistein in ovarian cancer cells

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 7, 2013, Pages 1126-1132

  Xu, Linlin ^a,b   Xiang, Jingying ^c   Shen, Jian ^d   Zou, Xi ^d   Zhai, Sulan ^a   Yin, Yongxiang ^c   Li, Ping ^a   Wang, Xuerong ^a   Sun, Qingmin ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University   (China)

^d AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Genistein; Microrna 27a (mir 27a); Ovarian cancer; Skov3; Sprouty2; Target gene

Indexed keywords

GENISTEIN; MICRORNA; MICRORNA 27A; SPROUTY PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANTICARCINOGENIC AGENTS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICRORNAS; OVARIAN NEOPLASMS; OVARY;

EID: 84882755582     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113139990006     Document Type: Article

References (33)

1. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010. CA: Cancer J. Clin., 2010, 60(5), 277-300.
2. Cragun, J.M. Screening for ovarian cancer. Cancer Control: J. Moffitt Cancer Center, 2011, 18(1), 16-21.
3. Cannistra, S.A. Cancer of the ovary. New Engl. J. Med., 2004, 351(24), 2519-2529.
4. Bartel, D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 2004, 116 (2), 281-297.
5. Saxena, S.; Jonsson, Z.O.; Dutta, A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol. Chem., 2003, 278(45), 44312-44319.
6. Esquela-Kerscher, A.; Slack, F.J. Oncomirs -microRNAs with a role in cancer. Nat. Rev. Cancer, 2006, 6(4), 259-269.
7. Zhang, B.; Pan, X.; Cobb, G.P.; Anderson, T.A. microRNAs as oncogenes and tumor suppressors. Developmental Biol., 2007, 302(1), 1-12.
8. Mertens-Talcott, S.U.; Chintharlapalli, S.; Li, X.; Safe, S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDAMB-231 breast cancer cells. Cancer Res., 2007, 67(22), 11001-11011.
9. Chintharlapalli, S.; Papineni, S.; Abdelrahim, M.; Abudayyeh, A.; Jutooru, I.; Chadalapaka, G.; Wu, F.; Mertens-Talcott, S.; Vanderlaag, K.; Cho, S.D.; Smith, R., 3rd; Safe, S. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. Int. J. Cancer, 2009, 125(8), 1965-1974.
10. Pathi, S.S.; Jutooru, I.; Chadalapaka, G.; Sreevalsan, S.; Anand, S.; Thatcher, G.R.; Safe, S. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen speciesmicroRNA-27a: ZBTB10-specificity protein pathway. Mol. Cancer Res., 2011, 9(2), 195-202.
11. Sun, Q.; Gu, H.; Zeng, Y.; Xia, Y.; Wang, Y.; Jing, Y.; Yang, L.; Wang, B. Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci., 2010, 101(10), 2241-2247.
12. Dixon, R.A.; Ferreira, D. Genistein. Phytochemistry, 2002, 60(3), 205-211.
13. Chen, Y.; Zaman, M.S.; Deng, G.; Majid, S.; Saini, S.; Liu, J.; Tanaka, Y.; Dahiya, R. MicroRNAs 221/222 and genisteinmediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev. Res. (Phila), 2011, 4(1), 76-86.
14. Li, Y.; Vandenboom, T.G., 2nd; Wang, Z.; Kong, D.; Ali, S.; Philip, P.A.; Sarkar, F.H. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res., 2010, 70(4), 1486-1495.
15. Tsuji, S.; Hisaoka, M.; Morimitsu, Y.; Hashimoto, H.; Shimajiri, S.; Komiya, S.; Ushijima, M.; Nakamura, T. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcriptionpolymerase chain reaction using archival paraffin-embedded tissues. Am. J. Pathol., 1998, 153(6), 1807-1812.
16. Sun, S.Y.; Yue, P.; Dawson, M.I.; Shroot, B.; Michel, S.; Lamph, W.W.; Heyman, R.A.; Teng, M.; Chandraratna, R.A.; Shudo, K.; Hong, W.K.; Lotan, R. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human nonsmall cell lung carcinoma cells. Cancer Res., 1997, 57(21), 4931-4939.
17. Ambros, V. The functions of animal microRNAs. Nature, 2004, 431(7006), 350-355.
18. Wang, C.J.; Zhou, Z.G.; Wang, L.; Yang, L.; Zhou, B.; Gu, J.; Chen, H.Y.; Sun, X.F. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Disease Markers, 2009, 26(1), 27-34.
19. Ma, L.; Reinhardt, F.; Pan, E.; Soutschek, J.; Bhat, B.; Marcusson, E.G.; Teruya-Feldstein, J.; Bell, G.W.; Weinberg, R.A. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat. Biotechnol., 2010, 28(4), 341-347.
20. Liu, T.; Tang, H.; Lang, Y.; Liu, M.; Li, X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett., 2009, 273(2), 233-242.
21. Ullrich, A.; Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 1990, 61(2), 203-212.
22. Pavese, J.M.; Farmer, R.L.; Bergan, R.C. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metast. Rev., 2010, 29, (3), 465-482.
23. Wang, Z.; Ahmad, A.; Banerjee, S.; Azmi, A.; Kong, D.; Li, Y.; Sarkar, F.H. FoxM1 is a novel target of a natural agent in pancreatic cancer. Pharmaceut. Res., 2010, 27(6), 1159-1168.
24. Wang, B.; Zou, Y.; Li, H.; Yan, H.; Pan, J.S.; Yuan, Z.L. Genistein inhibited retinal neovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor 1alpha in a mouse model of oxygen-induced retinopathy. J. Ocular Pharmacol. Therapeut., 2005, 21(2), 107-113.
25. Li, Q.S.; Li, C.Y.; Li, Z.L.; Zhu, H.L. Genistein and its synthetic analogs as anticancer agents. Anti-Cancer Agents Med. Chem., 2012, 12(3), 271-281.
26. Sahin, K.; Tuzcu, M.; Basak, N.; Caglayan, B.; Kilic, U.; Sahin, F.; Kucuk, O. Sensitization of cervical cancer cells to cisplatin by genistein: The role of NFkappaB and Akt/mTOR signaling pathways. J. Oncol., 2012, 2012, 461562.
27. Liang, C.; Li, H.; Shen, C.; Lai, J.; Shi, Z.; Liu, B.; Tao, H.M. Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of Akt and nuclear factor-kappaB pathway. Anti-Cancer Agents Med. Chem., 2012, 12(5), 554-563.
28. Xia, J.; Duan, Q.; Ahmad, A.; Bao, B.; Benerjee, S.; Shi, Y.; Ma, J.; Geng, J.; Chen, Z.; Rahman, K.M.; Miele, L.; Sarkar, F.H.; Wang, Z. Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Current Drug Targets, 2012, 13(14), 1750-1756.
29. Holgren, C.; Dougherty, U.; Edwin, F.; Cerasi, D.; Taylor, I.; Fichera, A.; Joseph, L.; Bissonnette, M.; Khare, S. Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: Sprouty/c-Met upregulation in human colonic adenocarcinomas. Oncogene, 2010, 29(38), 5241-5253.
30. Lo, T.L.; Yusoff, P.; Fong, C.W.; Guo, K.; McCaw, B.J.; Phillips, W.A.; Yang, H.; Wong, E.S.; Leong, H.F.; Zeng, Q.; Putti, T.C.; Guy, G.R. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res., 2004, 64(17), 6127-6136.
31. McKie, A.B.; Douglas, D.A.; Olijslagers, S.; Graham, J.; Omar, M.M.; Heer, R.; Gnanapragasam, V.J.; Robson, C.N.; Leung, H.Y. Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer. Oncogene, 2005, 24(13), 2166-2174.
32. Kwak, H.J.; Kim, Y.J.; Chun, K.R.; Woo, Y.M.; Park, S.J.; Jeong, J.A.; Jo, S.H.; Kim, T.H.; Min, H.S.; Chae, J.S.; Choi, E.J.; Kim, G.; Shin, S.H.; Gwak, H.S.; Kim, S.K.; Hong, E.K.; Lee, G.K.; Choi, K.H.; Kim, J.H.; Yoo, H.; Park, J.B.; Lee, S.H. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene, 2011, 30(21), 2433-2442.
33. Ma, Y.; Yu, S.; Zhao, W.; Lu, Z.; Chen, J. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett., 2010, 298(2), 150-158.